Don't Miss Any Side.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Social Media
Artificial Intelligence
Donald Trump
Education
European Union
World Cup
Heatwaves
Amazon
Taxes
NATO
NHL
Stock Markets
Labiotech.eu image

News from Labiotech.eu

Information about Labiotech.eu

Where is Labiotech.eu located?Labiotech.eu's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Labiotech.eu News

Turning Plastic Into Fuel: Photos of Gaza's Youth Surviving with Makeshift Burners
Plastics · Gaza

Turning Plastic Into Fuel: Photos of Gaza's Youth Surviving with Makeshift Burners

61% Left coverage: 18 sources
GAZA CITY, Gaza Strip (AP) — South of Gaza City, along the Sea Road that runs beside the Mediterranean, Palestinian youth are producing fuel by melting plastic in makeshift burners. With limited access to commercial fuel, they collect plastic waste,…See the Story
San Anselmo Resident, a Genetic Carrier of ALS, Fights to Cure the Disease
Medical

San Anselmo Resident, a Genetic Carrier of ALS, Fights to Cure the Disease

100% Center coverage: 2 sources
San Anselmo resident Mindy Uhrlaub, left, pictured with her mom. (Courtesy of Mindy Uhrlaub)(Courtesy of River Grove Books)Show Caption1 of 2San Anselmo resident Mindy Uhrlaub, left, pictured with her mom. (Courtesy of Mindy Uhrlaub)Expand When Mindy Uhrlaub got tested to see if she was a carrier of the fatal mutation that causes the amyotrophic lateral sclerosis (ALS) her mom had, her neurogeneticist at Stanford told her that if she was negativ…See the Story
Psychedelics sans side effects: neuroplastogens gain ground
Psychedelics

Psychedelics sans side effects: neuroplastogens gain ground

The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders. The post Psychedelics sans side effects: neuroplastogens gain ground appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and l…Read Article

Blindspots

Turning Plastic Into Fuel: Photos of Gaza's Youth Surviving with Makeshift Burners
Low coverage from Right Sources

Turning Plastic Into Fuel: Photos of Gaza's Youth Surviving with Makeshift Burners

100% of Sources are High Factuality

Chronic lymphocytic leukemia: time to rethink treatment strategies?

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live beyond uncertainty. The post How can treatment strategies evolve to address the challenges in chronic lymphocytic leukemia? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strict…Read Article

Illuminating biotech in the City of Light: Inside Paris's thriving ecosystem

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters in Europe. The post Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts …Paris, France · ParisRead Article

New Florida Law Opens $15.1B Stem Cell Market: ADIA Med Clinic Launches Free Consultations

Florida's SB 1768 greenlights stem cell treatments starting July 1. ADIA Med offers free consultations, clinic partnerships. Discover how this impacts healthcare delivery.Florida, United States · FloridaSee the Story

10 cultured meat companies driving sustainable food in 2025

Learn more about 10 of the top cultured meat companies in biotech looking to pave the way for a sustainable future. The post 10 cultured meat companies driving sustainable food in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that …Germany · GermanyRead Article

The Rise Of STAT6 Degraders - Data Intelligence

Newsletter Signup – Under Article / In Page “*” indicates required fields For years, STAT6, a key transcription factor in allergic diseases like asthma and atopic dermatitis, was considered off-limits. Traditional small molecules couldn’t get a grip on it. There were no neat pockets to bind, no enzymes to inhibit.  Yet STAT6 plays a central role in Th2-driven diseases. Activated by interleukins 4 and 13, it drives the production of IgE, fuels in…Germany · GermanySee the Story

Vivoryon's Kidney Disease Breakthrough: Patent Extension and Phase 2b Plans Signal Major Progress

Vivoryon secures crucial US patent for varoglutamstat through 2044, advances Phase 2b kidney disease trial prep, and reports Q1 financials. Get full development timeline.United States · United StatesSee the Story

Semaglutide Patent Expiry Opens Door To GLP-1 Generics In Canada - Data Intelligence

Newsletter Signup – Under Article / In Page “*” indicates required fields In 2020, Novo Nordisk’s Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired. The reason? A small missed maintenance fee, reportedly around  1,200 Canadian dollars. The lapse went largely unnoticed until it was recently highlighted by Derek Lowe in Science, where he described it as an eyebrow-raising mome…Ozempic · CanadaSee the Story

A New Era In Migraine Treatment: Promising Drugs In Development - Data Intelligence

Newsletter Signup – Under Article / In Page “*” indicates required fields Migraines are not simply a bad headache; they are a neurological disorder that can significantly impact daily life. Often characterized by throbbing pain on one side of the head, they can be moderate to severe and are often accompanied by nausea, vomiting, and sensitivity to light and sound. Migraine treatment generally focuses on managing acute attacks and, in some cases,…Germany · GermanySee the Story

Breaking News Topics Related to Labiotech.eu

Germany icon

Germany

United States icon

United States

Medical icon

Medical

News
For You
SearchBlindspotLocal